Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


Lens replacement material holds prospect of ’young’ eyes for people over 40


A gel-like material being developed by scientists at the VA Hospital and Washington University in St. Louis could eventually mean the end of bifocals and contacts for millions of middle age and older people who suffer from presbyopia — literally "old vision." The material, which could be used to replace old hardened lenses in patients, including those with cataracts, was described today at the 226th national meeting of the American Chemical Society, the world’s largest scientific society.

While not a life-threatening condition, presbyopia affects nearly everyone over the age of about 40 or 45. As people age, according to one theory, the lenses in their eyes slowly harden making it more and more difficult to focus on nearby objects. The current solution for most people is reading glasses or contacts. Even people who undergo corrective laser surgery often still need glasses for reading and up close focusing.

"Our idea is that if we can remove the lens and put in a material that is soft, like a young healthy lens is at age 20, then they would have their accommodative ability restored," says researcher Madalene Fetsch. "They would be able to focus on near and far objects."

Fetsch, a graduate assistant in Washington University’s department of biomedical engineering, is working under the mentorship of Dr. Nathan Ravi, M.D., Ph.D., principal investigator in the development of the replacement lens material. He is an associate professor of ophthalmology and professor of chemical engineering at the school. He also is director of ophthalmology for VA Heartland hospitals in the Midwest.

The material, which is currently in lab testing, is a hydrophobically modified hydrogel. Hydrogels are used in many extended wear contact lenses.

"The gels can be made soft to the touch and have viscoelastic properties similar to that of the natural human lens," according to Fetsch. "At the same time, our material so far looks like it has the potential to be injectable, which means less invasive surgery."

Other research groups are also working on replacement lens materials, but Fetsch believes her material is different in several ways. One significant difference, she says, is reversible disulfide bonds. "This means that after forming the gel, we can reduce the bonds, liquefying the gel again so that it can be injected into the lens capsular bag." Once in the bag, the material reforms to a gel under natural physiological conditions.

One advantage of this is that only a very small injection hole is required to place the lens material in the bag, thus avoiding the common surgical technique of cutting a slit to insert a replacement lens. Fetsch says the hole would be small enough that stitches would not be required after the lens material is placed in the capsular bag.

Fetsch is hopeful that animal testing can begin in one year. But first, the researchers have to improve the materials’ refractive index — the degree at which it refracts light, which is key to how well you can focus with the material.

"Right now, in this particular system, that’s a little low," Fetsch admits. "It’s not good enough to be able to see more than blurry. But it’s something we think we can bring up with just simple modifications." Other scientists have been successful in improving the refractive index in similar soft gels, according to the researchers.

The material the research group is using to form the reversible bonds — acrylamide — is a known neurotoxin, but Fetsch doesn’t think that will be a problem because the acrylamide is polymerized.

"It sounds ludicrous to put [acrylamide] in the body, but the idea is that polyacrylamide when it’s in long chains is not toxic to the body as far as we know," Fetsch says. Additionally, before injection, thorough washing of the material would get rid of any traces of acrylamide, she adds.

The polymerization process also can be used for other biocompatible acrylamide derivatives, the researchers say.

While acknowledging that there is still a lot of work left before an injectable lens could become a reality, Fetsch has an idea of how the material might be introduced.

"Assuming that we made it all the way to human studies, we probably would first offer it to cataract patients because by that time they almost certainly have presbyopia and they’re looking at a similar surgery anyway." After that, Fetsch says, it could be offered to people with presbyopia who otherwise have healthy vision but don’t want to wear glasses or contacts.

The Veteran’s Administration Merit Review Grant provided funding support for the research.

The poster on this research, PMSE 317, will be presented at 8:00 p.m., Monday, Sept. 8, at the Javits Convention Center, North Pavilion, during Sci-Mix, and at 5:30 p.m., Tuesday, Sept. 9, at the Hilton New York, Rhinelander Center, during a joint PMSE/POLY poster session.

Madalene D. Fetsch is a graduate assistant in the Department of Biomedical Engineering at Washington University’s School of Engineering and Applied Science in St. Louis, Mo.

V. Nathan Ravi, M.D., Ph.D., is an associate professor of ophthalmology and visual sciences at Washington University’s School of Medicine and professor of chemical engineering at Washington University in St. Louis, Mo., and the director of ophthalmology for VA Heartland hospitals in the Midwest.

Michael Bernstein | EurekAlert!
Further information:

More articles from Health and Medicine:

nachricht NIH scientists describe potential antibody treatment for multidrug-resistant K. pneumoniae
14.03.2018 | NIH/National Institute of Allergy and Infectious Diseases

nachricht Researchers identify key step in viral replication
13.03.2018 | University of Pittsburgh Schools of the Health Sciences

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Researchers at Fraunhofer monitor re-entry of Chinese space station Tiangong-1

In just a few weeks from now, the Chinese space station Tiangong-1 will re-enter the Earth's atmosphere where it will to a large extent burn up. It is possible that some debris will reach the Earth's surface. Tiangong-1 is orbiting the Earth uncontrolled at a speed of approx. 29,000 km/h.Currently the prognosis relating to the time of impact currently lies within a window of several days. The scientists at Fraunhofer FHR have already been monitoring Tiangong-1 for a number of weeks with their TIRA system, one of the most powerful space observation radars in the world, with a view to supporting the German Space Situational Awareness Center and the ESA with their re-entry forecasts.

Following the loss of radio contact with Tiangong-1 in 2016 and due to the low orbital height, it is now inevitable that the Chinese space station will...

Im Focus: Alliance „OLED Licht Forum“ – Key partner for OLED lighting solutions

Fraunhofer Institute for Organic Electronics, Electron Beam and Plasma Technology FEP, provider of research and development services for OLED lighting solutions, announces the founding of the “OLED Licht Forum” and presents latest OLED design and lighting solutions during light+building, from March 18th – 23rd, 2018 in Frankfurt a.M./Germany, at booth no. F91 in Hall 4.0.

They are united in their passion for OLED (organic light emitting diodes) lighting with all of its unique facets and application possibilities. Thus experts in...

Im Focus: Mars' oceans formed early, possibly aided by massive volcanic eruptions

Oceans formed before Tharsis and evolved together, shaping climate history of Mars

A new scenario seeking to explain how Mars' putative oceans came and went over the last 4 billion years implies that the oceans formed several hundred million...

Im Focus: Tiny implants for cells are functional in vivo

For the first time, an interdisciplinary team from the University of Basel has succeeded in integrating artificial organelles into the cells of live zebrafish embryos. This innovative approach using artificial organelles as cellular implants offers new potential in treating a range of diseases, as the authors report in an article published in Nature Communications.

In the cells of higher organisms, organelles such as the nucleus or mitochondria perform a range of complex functions necessary for life. In the networks of...

Im Focus: Locomotion control with photopigments

Researchers from Göttingen University discover additional function of opsins

Animal photoreceptors capture light with photopigments. Researchers from the University of Göttingen have now discovered that these photopigments fulfill an...

All Focus news of the innovation-report >>>



Industry & Economy
Event News

Virtual reality conference comes to Reutlingen

19.03.2018 | Event News

Ultrafast Wireless and Chip Design at the DATE Conference in Dresden

16.03.2018 | Event News

International Tinnitus Conference of the Tinnitus Research Initiative in Regensburg

13.03.2018 | Event News

Latest News

TRAPPIST-1 planets provide clues to the nature of habitable worlds

21.03.2018 | Physics and Astronomy

The search for dark matter widens

21.03.2018 | Materials Sciences

Natural enemies reduce pesticide use

21.03.2018 | Life Sciences

Science & Research
Overview of more VideoLinks >>>